204 related articles for article (PubMed ID: 1360200)
1. Negative symptoms and hypofrontality in chronic schizophrenia.
Wolkin A; Sanfilipo M; Wolf AP; Angrist B; Brodie JD; Rotrosen J
Arch Gen Psychiatry; 1992 Dec; 49(12):959-65. PubMed ID: 1360200
[TBL] [Abstract][Full Text] [Related]
2. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients.
Siegel BV; Buchsbaum MS; Bunney WE; Gottschalk LA; Haier RJ; Lohr JB; Lottenberg S; Najafi A; Nuechterlein KH; Potkin SG
Am J Psychiatry; 1993 Sep; 150(9):1325-36. PubMed ID: 8352343
[TBL] [Abstract][Full Text] [Related]
3. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
Semkovska M; Bédard MA; Stip E
Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
[TBL] [Abstract][Full Text] [Related]
4. Low frontal glucose utilization in chronic schizophrenia: a replication study.
Wolkin A; Angrist B; Wolf A; Brodie JD; Wolkin B; Jaeger J; Cancro R; Rotrosen J
Am J Psychiatry; 1988 Feb; 145(2):251-3. PubMed ID: 3257653
[TBL] [Abstract][Full Text] [Related]
5. Phenomenological correlates of metabolic activity in 18 patients with chronic schizophrenia.
Volkow ND; Wolf AP; Van Gelder P; Brodie JD; Overall JE; Cancro R; Gomez-Mont F
Am J Psychiatry; 1987 Feb; 144(2):151-8. PubMed ID: 3492931
[TBL] [Abstract][Full Text] [Related]
6. Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London.
Andreasen NC; Rezai K; Alliger R; Swayze VW; Flaum M; Kirchner P; Cohen G; O'Leary DS
Arch Gen Psychiatry; 1992 Dec; 49(12):943-58. PubMed ID: 1360199
[TBL] [Abstract][Full Text] [Related]
7. Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics.
Buchsbaum MS; Haier RJ; Potkin SG; Nuechterlein K; Bracha HS; Katz M; Lohr J; Wu J; Lottenberg S; Jerabek PA
Arch Gen Psychiatry; 1992 Dec; 49(12):935-42. PubMed ID: 1360198
[TBL] [Abstract][Full Text] [Related]
8. Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography.
Wolkin A; Jaeger J; Brodie JD; Wolf AP; Fowler J; Rotrosen J; Gomez-Mont F; Cancro R
Am J Psychiatry; 1985 May; 142(5):564-71. PubMed ID: 3872603
[TBL] [Abstract][Full Text] [Related]
9. Toward a brain map of auditory hallucinations.
Cleghorn JM; Franco S; Szechtman B; Kaplan RD; Szechtman H; Brown GM; Nahmias C; Garnett ES
Am J Psychiatry; 1992 Aug; 149(8):1062-9. PubMed ID: 1353314
[TBL] [Abstract][Full Text] [Related]
10. Correlations of phosphomonoesters measured by phosphorus-31 magnetic resonance spectroscopy in the frontal lobes and negative symptoms in schizophrenia.
Shioiri T; Kato T; Inubushi T; Murashita J; Takahashi S
Psychiatry Res; 1994 Dec; 55(4):223-35. PubMed ID: 7701036
[TBL] [Abstract][Full Text] [Related]
11. Hypofrontality in schizophrenia as assessed by PET.
Buchsbaum MS; Wu JC
Am J Psychiatry; 1987 Jan; 144(1):122-3. PubMed ID: 2879481
[No Abstract] [Full Text] [Related]
12. The brain metabolic patterns of clozapine- and fluphenazine-treated patients with schizophrenia during a continuous performance task.
Cohen RM; Nordahl TE; Semple WE; Andreason P; Litman RE; Pickar D
Arch Gen Psychiatry; 1997 May; 54(5):481-6. PubMed ID: 9152102
[TBL] [Abstract][Full Text] [Related]
13. Altered frontostriatal relationship in unmedicated schizophrenic patients.
Biver F; Goldman S; Luxen A; Delvenne V; De Maertelaer V; De La Fuente J; Mendlewicz J; Lotstra F
Psychiatry Res; 1995 Sep; 61(3):161-71. PubMed ID: 8545500
[TBL] [Abstract][Full Text] [Related]
14. Comparison of PET measurement of local brain glucose metabolism and CAT measurement of brain atrophy in chronic schizophrenia and depression.
Kling AS; Metter EJ; Riege WH; Kuhl DE
Am J Psychiatry; 1986 Feb; 143(2):175-80. PubMed ID: 3946650
[TBL] [Abstract][Full Text] [Related]
15. Observation of metabolic changes in chronic schizophrenia after neuroleptic treatment by in vivo hydrogen magnetic resonance spectroscopy.
Choe BY; Suh TS; Shinn KS; Lee CW; Lee C; Paik IH
Invest Radiol; 1996 Jun; 31(6):345-52. PubMed ID: 8761867
[TBL] [Abstract][Full Text] [Related]
16. Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia.
Szechtman H; Nahmias C; Garnett ES; Firnau G; Brown GM; Kaplan RD; Cleghorn JM
Arch Gen Psychiatry; 1988 Jun; 45(6):523-32. PubMed ID: 2897836
[TBL] [Abstract][Full Text] [Related]
17. Structural and functional correlates of subsyndromes in chronic schizophrenia.
Schröder J; Buchsbaum MS; Siegel BV; Geider FJ; Niethammer R
Psychopathology; 1995; 28(1):38-45. PubMed ID: 7871119
[TBL] [Abstract][Full Text] [Related]
18. Unawareness of illness in chronic schizophrenia and its relationship to structural brain measures and neuropsychological tests.
Larøi F; Fannemel M; Rønneberg U; Flekkøy K; Opjordsmoen S; Dullerud R; Haakonsen M
Psychiatry Res; 2000 Nov; 100(1):49-58. PubMed ID: 11090725
[TBL] [Abstract][Full Text] [Related]
19. Reduced frontal and occipital lobe asymmetry on the CT-scans of schizophrenic patients. Its specificity and clinical significance.
Falkai P; Schneider T; Greve B; Klieser E; Bogerts B
J Neural Transm Gen Sect; 1995; 99(1-3):63-77. PubMed ID: 8579808
[TBL] [Abstract][Full Text] [Related]
20. Regional brain glucose metabolism in chronic schizophrenia. A positron emission transaxial tomographic study.
Farkas T; Wolf AP; Jaeger J; Brodie JD; Christman DR; Fowler JS
Arch Gen Psychiatry; 1984 Mar; 41(3):293-300. PubMed ID: 6608333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
